KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
KAMADA LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 21.7
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 12, 2026 | Before market open | $54.90M | $0.16 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 13, 2026 | Before market open | $45.20M | $0.07 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 11, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | Before market open | $47.00M | $0.09 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | Before market open | $44.80M | $0.13 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 14, 2025 | Before market open | $44.00M | $0.07 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 5, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 13, 2024 | Before market open | $41.70M | $0.07 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 6, 2024 | Before market open | $36.40M | $0.09 | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 16, 2023 | Before market open | $37.40M | $0.04 | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 24, 2023 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 12, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EBITDAnon-GAAP | 2026 annual | $50.00M to $53.00M | Maintained |
| total revenuesGAAP | 2026 annual | $200.00M to $205.00M | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Kamada filed with the SEC
RESPONSE TO SEC COMMENT LETTER DATED SEPTEMBER 25, 2026
EX-99.1 to Form 6-K
COMPANY'S PRESENTATION - AUGUST 2026
EX-99.2 to Form 6-K
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
EX-99.3 to Form 6-K
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
EX-99.2 to Form 6-K
COMPANY'S PRESENTATION - MAY 2026
EX-99.2 to Form 6-K
AS OF MARCH 31, 2026
EX-99.3 to Form 6-K
KAMADA TO ANNOUNCE FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 13, 2026
EX-99.1 to Form 6-K
CORPORATE PRESENTATION - JANUARY 2026
EX-99.2 to Form 6-K
KAMADA ANNOUNCES A $10-$14 MILLION EXTENSION OF CANADIAN SUPPLY TENDER
EX-99.1 to Form 6-K
COMPENSATION POLICY FOR OFFICE HOLDERS OF THE COMPANY
EX-99.1 to Form 6-K
AMENDED ARTICLES OF ASSOCIATION OF THE COMPANY
EX-99.2 to Form 6-K
COMPANY'S PRESENTATION - NOVEMBER 2025
EX-99.2 to Form 6-K
AS OF September 30, 2025
EX-99.3 to Form 6-K
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD
EX-99.2 to Form 6-K
KAMADA TO PARTICIPATE IN UPCOMING SEPTEMBER INVESTOR CONFERENCES
EX-99.1 to Form 6-K
COMPANY'S PRESENTATION - AUGUST 2025
EX-99.2 to Form 6-K